UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

British journal of cancer, 2019-10, Vol.121 (7), p.600-610

2019

Volltextzugriff (PDF)

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

Cancers, 2019-11, Vol.11 (11), p.1713

2019

Volltextzugriff (PDF)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib

Translational oncology, 2017-04, Vol.10 (2), p.190-196

2017

Volltextzugriff (PDF)

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients

PloS one, 2021-01, Vol.16 (1), p.e0241240

2021

Volltextzugriff (PDF)

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada

Current oncology (Toronto), 2021-08, Vol.28 (4), p.3091-3103

2021

Volltextzugriff (PDF)

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

JTO clinical and research reports, 2021-12, Vol.2 (12), p.100249-100249, Article 100249

2021

Volltextzugriff (PDF)

ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors

Molecular cancer therapeutics, 2010-02, Vol.9 (2), p.347-357

2010

Volltextzugriff (PDF)

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Metabolomics, 2016-03, Vol.12 (3), p.58-58, Article 58

2016

Volltextzugriff (PDF)

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers

Pulmonary therapy, 2023-09, Vol.9 (3), p.435-450

2023

Volltextzugriff (PDF)

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

Journal of hematology and oncology, 2023-06, Vol.16 (1), p.66-66, Article 66

2023

Volltextzugriff (PDF)

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults

Current oncology (Toronto), 2021-01, Vol.28 (1), p.523-548

2021

Volltextzugriff (PDF)

Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer

BMC cancer, 2021-02, Vol.21 (1), p.159-159, Article 159

2021

Volltextzugriff (PDF)

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

British journal of cancer, 2020-06, Vol.122 (12), p.1872-1872

2020

Volltextzugriff (PDF)

The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-12, Vol.3 (12), p.1379-1383

2008

Volltextzugriff (PDF)

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database

Current oncology (Toronto), 2021-10, Vol.28 (5), p.4213-4222

2021

Volltextzugriff (PDF)

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

JTO clinical and research reports, 2021-04, Vol.2 (4), p.100157-100157, Article 100157

2021

Volltextzugriff (PDF)

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests

Current oncology (Toronto), 2022-12, Vol.29 (12), p.9916-9927

2022

Volltextzugriff (PDF)

Development of an algorithm to identify small cell lung cancer patients in claims databases

Frontiers in oncology, 2024-08, Vol.14

2024

Volltextzugriff (PDF)

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines

Cell cycle (Georgetown, Tex.), 2014-07, Vol.13 (13), p.2129-2137

2014

Volltextzugriff (PDF)

Predicting PARP inhibitor sensitivity and resistance

Cell cycle (Georgetown, Tex.), 2012-11, Vol.11 (22), p.4110-4110

2012

Volltextzugriff (PDF)

Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients

PloS one, 2017-08, Vol.12 (8), p.e0181867-e0181867

2017

Volltextzugriff (PDF)

Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study

Lung cancer (Amsterdam, Netherlands), 2024-07, Vol.193, p.107819, Article 107819

2024

Volltextzugriff (PDF)

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort

Current oncology (Toronto), 2022-03, Vol.29 (3), p.1967-1982

2022

Volltextzugriff (PDF)

Erratum to: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Metabolomics, 2016-07, Vol.12 (7), p.1, Article 122

2016

Volltextzugriff (PDF)

Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study

American journal of clinical oncology, 2020-09, Vol.43 (9), p.615

2020

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(58)
Oncology
(45)
Humans
(43)
Female
(28)
Male
(24)
Middle Aged
(20)
Aged
(18)
Lung Cancer
(15)
Lung Neoplasms - Pathology
(13)
Carcinoma, Non-Small-Cell Lung - Pathology
(12)
Retrospective Studies
(12)
Adult
(11)
Cancer
(11)
Lung Neoplasms - Drug Therapy
(11)
Non-Small Cell Lung Cancer
(11)
Respiratory System
(10)
Aged, 80 And Over
(9)
Biological And Medical Sciences
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(21)
Journal Of Clinical Oncology
(13)
Current Oncology
(7)
Lung Cancer
(6)
Blood
(3)
American Journal Of Clinical Oncology
(2)
Bmc Cancer
(2)
British Journal Of Cancer
(2)
Cell Cycle
(2)
Cell Cycle/cell Cycle
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults

Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests

Development of an algorithm to identify small cell lung cancer patients in claims databases

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines

Predicting PARP inhibitor sensitivity and resistance

Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients

Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort

Erratum to: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study

Suchergebnisse filtern